Abstract
Surgical revascularization is now accepted as an effective treatment to reduce the incidence of subsequent cerebrovascular events, including ischemic and hemorrhagic stroke, although precise analysis of long-term outcome after surgery is required. In this Part V “Real World of Surgical Revascularization for Moyamoya Disease,” very skillful and experienced neurosurgeons around the world would discuss their surgical technique and long-term outcome in patients with moyamoya disease. It also includes special topics on perioperative complications, indirect bypass, combined bypass, and unique clinical features in infantile and elderly patients. In this chapter, I briefly overview surgical techniques for moyamoya disease and describe recent data on postoperative, long-term (>10 years) outcome in Japan.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Kraemer M, Berlit P, Diesner F, Khan N. What is the expert’s option on antiplatelet therapy in moyamoya disease? Results of a worldwide survey. European journal of neurology: the official journal of the European Federation of Neurological Societies. 2012;19:163–7.
Yamada S, Oki K, Itoh Y, Kuroda S, Houkin K, Tominaga T, Miyamoto S, Hashimoto N, Suzuki N, Research Committee on Spontaneous Occlusion of Circle of W. Effects of surgery and antiplatelet therapy in ten-year follow-up from the registry study of research committee on Moyamoya disease in Japan. J Stroke Cerebrovasc Dis. 2016;25:340–9.
Kuroda S, Houkin K. Moyamoya disease: current concepts and future perspectives. Lancet Neurol. 2008;7:1056–66.
Miyamoto S, Yoshimoto T, Hashimoto N, Okada Y, Tsuji I, Tominaga T, Nakagawara J, Takahashi JC, Investigators JT. Effects of extracranial-intracranial bypass for patients with hemorrhagic moyamoya disease: results of the Japan adult moyamoya trial. Stroke. 2014;45:1415–21.
Takahashi JC, Funaki T, Houkin K, Inoue T, Ogasawara K, Nakagawara J, Kuroda S, Yamada K, Miyamoto S, Investigators JAMT. Significance of the hemorrhagic site for recurrent bleeding: Prespecified analysis in the Japan adult Moyamoya trial. Stroke. 2016;47:37–43.
Funaki T, Takahashi JC, Takagi Y, Kikuchi T, Yoshida K, Mitsuhara T, Kataoka H, Okada T, Fushimi Y, Miyamoto S. Unstable moyamoya disease: clinical features and impact on perioperative ischemic complications. J Neurosurg. 2015;122:400–7.
Houkin K, Ishikawa T, Yoshimoto T, Abe H. Direct and indirect revascularization for moyamoya disease surgical techniques and peri-operative complications. Clin Neurol Neurosurg. 1997;99(Suppl 2):S142–5.
Iwama T, Hashimoto N, Tsukahara T, Murai B. Peri-operative complications in adult moyamoya disease. Acta Neurochir. 1995;132:26–31.
Kazumata K, Ito M, Tokairin K, Ito Y, Houkin K, Nakayama N, Kuroda S, Ishikawa T, Kamiyama H. The frequency of postoperative stroke in moyamoya disease following combined revascularization: a single-university series and systematic review. J Neurosurg. 2014;121:432–40.
Kim SH, Choi JU, Yang KH, Kim TG, Kim DS. Risk factors for postoperative ischemic complications in patients with moyamoya disease. J Neurosurg. 2005;103:433–8.
Kuroda S, Houkin K, Ishikawa T, Nakayama N, Iwasaki Y. Novel bypass surgery for moyamoya disease using pericranial flap: its impacts on cerebral hemodynamics and long-term outcome. Neurosurgery. 2010;66:1093–101. discussion 1101
Kuroda S, Nakayama N, Yamamoto S, Kashiwazaki D, Uchino H, Saito H, Hori E, Akioka N, Kuwayama N, Houkin K. Late (5-20 years) outcomes after STA-MCA anastomosis and encephalo-duro-myo-arterio-pericranial synangiosis in patients with moyamoya disease. J Neurosurg. 2020:1–8.
Sato K, Shirane R, Yoshimoto T. Perioperative factors related to the development of ischemic complications in patients with moyamoya disease. Childs Nerv Syst. 1997;13:68–72.
Matsushima T, Inoue K, Kawashima M, Inoue T. History of the development of surgical treatments for moyamoya disease. Neurol Med Chir (Tokyo). 2012;52:278–86.
Komotar RJ, Starke RM, Otten ML, Merkow MB, Garrett MC, Marshall RS, Elkind MS, Connolly ES. The role of indirect extracranial-intracranial bypass in the treatment of symptomatic intracranial atheroocclusive disease. J Neurosurg. 2009;110:896–904.
Henschen C. Surgical revascularization of cerebral injury of circulatory origin by means of stratification of pedunculated muscle flaps. Langenbecks Arch Klin Chir Ver Dtsch Z Chir. 1950;264:392–401.
Tsubokawa T, Kikuchi M, Asano S, Ito H, Urabe M. Surgical treatment for intracranial thrombosis - case report of “durapexia”. Neurol Med Chir (Tokyo). 1964;6:48–9.
Karasawa J, Kikuchi H, Furuse S, Sakaki T, Yoshida Y. A surgical treatment of "moyamoya" disease "encephalo-myo synangiosis". Neurol Med Chir (Tokyo). 1977;17:29–37.
Matsushima Y, Fukai N, Tanaka K, Tsuruoka S, Inaba Y, Aoyagi M, Ohno K. A new surgical treatment of moyamoya disease in children: a preliminary report. Surg Neurol. 1981;15:313–20.
Karasawa J, Kikuchi H, Kawamura J, Sakai T. Intracranial transplantation of the omentum for cerebrovascular moyamoya disease: a two-year follow-up study. Surg Neurol. 1980;14:444–9.
Yoshioka N, Tominaga S, Suzuki Y, Yamazato K, Hirano S, Nonaka K, Inui T, Matuoka N. Cerebral revascularization using omentum and muscle free flap for ischemic cerebrovascular disease. Surg Neurol. 1998;49:58–65. discussion 65-56
Hayashi T, Yamamoto S, Hamashima T, Mori H, Sasahara M, Kuroda S. Critical role of platelet-derived growth factor-alpha in angiogenesis after indirect bypass in a murine moyamoya disease model. J Neurosurg. 2020:1–9.
Kang HS, Kim JH, Phi JH, Kim YY, Kim JE, Wang KC, Cho BK, Kim SK. Plasma matrix metalloproteinases, cytokines and angiogenic factors in moyamoya disease. J Neurol Neurosurg Psychiatry. 2010;81:673–8.
Marushima A, Nieminen M, Kremenetskaia I, Gianni-Barrera R, Woitzik J, von Degenfeld G, Banfi A, Vajkoczy P, Hecht N. Balanced single-vector co-delivery of VEGF/PDGF-BB improves functional collateralization in chronic cerebral ischemia. J Cereb Blood Flow Metab. 2020;40:404–19.
Mizoi K, Kayama T, Yoshimoto T, Nagamine Y. Indirect revascularization for moyamoya disease: is there a beneficial effect for adult patients? Surg Neurol. 1996;45:541–8. discussion 548–549
Uchino H, Kim JH, Fujima N, Kazumata K, Ito M, Nakayama N, Kuroda S, Houkin K. Synergistic interactions between direct and indirect bypasses in combined procedures: the significance of indirect bypasses in Moyamoya disease. Neurosurgery. 2017;80:201–9.
Ishikawa T, Houkin K, Kamiyama H, Abe H. Effects of surgical revascularization on outcome of patients with pediatric moyamoya disease. Stroke. 1997;28:1170–3.
Kuroda S, Houkin K, Ishikawa T, Nakayama N, Ikeda J, Ishii N, Kamiyama H, Iwasaki Y. Determinants of intellectual outcome after surgical revascularization in pediatric moyamoya disease: a multivariate analysis. Childs Nerv Syst. 2004;20:302–8.
Hori S, Kashiwazaki D, Akioka N, Hayashi T, Hori E, Umemura K, Horie Y, Kuroda S. Surgical anatomy and preservation of the middle meningeal artery during bypass surgery for moyamoya disease. Acta Neurochir. 2015;157:29–36.
Tanabe N, Yamamoto S, Kashiwazaki D, Akioka N, Kuwayama N, Noguchi K, Kuroda S. Indocyanine green visualization of middle meningeal artery before craniotomy during surgical revascularization for moyamoya disease. Acta Neurochir. 2017;159:567–75.
Krayenbuhl HA. The Moyamoya syndrome and the neurosurgeon. Surg Neurol. 1975;4:353–60.
Yonekawa Y. Operative neurosurgery: personal view and historical backgrounds (9) Moyamoya Angiopathy (MMA): past history and status Presens. No Shinkei Geka. 2012;40:67–87.
Karasawa J, Kikuchi H, Furuse S, Kawamura J, Sakaki T. Treatment of moyamoya disease with STA-MCA anastomosis. J Neurosurg. 1978;49:679–88.
Karasawa J, Touho H, Ohnishi H, Miyamoto S, Kikuchi H. Long-term follow-up study after extracranial-intracranial bypass surgery for anterior circulation ischemia in childhood moyamoya disease. J Neurosurg. 1992;77:84–9.
Takagi Y, Hermanto Y, Takahashi JC, Funaki T, Kikuchi T, Mineharu Y, Yoshida K, Miyamoto S. Histopathological characteristics of distal middle cerebral artery in adult and pediatric patients with Moyamoya disease. Neurol Med Chir (Tokyo). 2016;56:345–9.
Kamiyama H, Takahashi A, Houkin K, Mabuchi S, Abe H. Visualization of the ostium of an arteriotomy in bypass surgery. Neurosurgery. 1993;33:1109–10.
Hayashi T, Shirane R, Tominaga T. Additional surgery for postoperative ischemic symptoms in patients with moyamoya disease: the effectiveness of occipital artery-posterior cerebral artery bypass with an indirect procedure: technical case report. Neurosurgery. 2009;64:E195–6. discussion E196
Iwama T, Hashimoto N, Miyake H, Yonekawa Y. Direct revascularization to the anterior cerebral artery territory in patients with moyamoya disease: report of five cases. Neurosurgery. 1998;42:1157–61. discussion 1161–1152
Teo M, Johnson J, Steinberg GK. Strategies for and outcome of repeat revascularization surgery for Moyamoya disease: an American institutional series. Neurosurgery. 2017;81:852–9.
Uchino H, Kashiwazaki D, Akioka N, Koh M, Kuwayama N, Houkin K, Kuroda S. Strategy and effect of repeat bypass surgery for anterior/posterior circulation in refractory moyamoya disease. J Neurosurg. 2019:1–11.
Amin-Hanjani S, Singh A, Rifai H, Thulborn KR, Alaraj A, Aletich V, Charbel FT. Combined direct and indirect bypass for moyamoya: quantitative assessment of direct bypass flow over time. Neurosurgery. 2013;73:962–7. discussion 967–968
Uchino H, Yamamoto S, Kashiwazaki D, Akioka N, Kuwayama N, Noguchi K, Kuroda S. Using postoperative remodeling of donor arteries on MR angiography to predict the development of surgical collaterals in moyamoya disease. J Neurosurg. 2019:1–9.
Suzuki J, Takaku A. Cerebrovascular “moyamoya” disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol. 1969;20:288–99.
Imaizumi T, Hayashi K, Saito K, Osawa M, Fukuyama Y. Long-term outcomes of pediatric moyamoya disease monitored to adulthood. Pediatr Neurol. 1998;18:321–5.
Mukawa M, Nariai T, Matsushima Y, Tanaka Y, Inaji M, Maehara T, Aoyagi M, Ohno K. Long-term follow-up of surgically treated juvenile patients with Moyamoya disease. J Neurosurg Pediatr. 2012;10:451–6.
Funaki T, Takahashi JC, Takagi Y, Yoshida K, Araki Y, Kikuchi T, Kataoka H, Iihara K, Sano N, Miyamoto S. Incidence of late cerebrovascular events after direct bypass among children with moyamoya disease: a descriptive longitudinal study at a single center. Acta Neurochir. 2014;156:551–9. discussion 559
Bao XY, Zhang Y, Wang QN, Zhang Q, Wang H, Zhang ZS, Li DS, Duan L. Long-term outcomes after Encephaloduroarteriosynangiosis in adult patients with Moyamoya disease presenting with ischemia. World Neurosurg. 2018;115:e482–9.
Acknowledgments
This work was partly supported by a grant from the Research Committee on Moyamoya Disease, the Japanese Ministry of Health, Labour and Welfare.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Kuroda, S. (2021). Overview of Surgical Revascularization and Long-Term Outcome in Japan. In: Kuroda, S. (eds) Moyamoya Disease: Current Knowledge and Future Perspectives. Springer, Singapore. https://doi.org/10.1007/978-981-33-6404-2_18
Download citation
DOI: https://doi.org/10.1007/978-981-33-6404-2_18
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-33-6403-5
Online ISBN: 978-981-33-6404-2
eBook Packages: MedicineMedicine (R0)